Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir in Pediatric Chronic Hepatitis B
NCT00423891Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2007
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 2, open-label, single-arm trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Bristol Myers Squibb. Primary endpoint: Number of Participants With Serious Adverse Events (SAE) and Discontinuations Due to Adverse Events (AEs). Started Jun 2007; status: completed.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00423891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00423891.